Midday movers: Lowe's and Zoom rise; Unity Software falls
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
TD Cowen Downgrades Macy's (M) to Market Perform, 'Prudent Bold New Changes Will Take Time to Drive Upside to Guidance'
February 29, 2024 5:29 AM ESTTD Cowen analyst Oliver Chen downgraded Macy's (NYSE: M) from Outperform to Market Perform with a price target of $20.00 (from $23.00).
The analyst comments "We like changes ahead including 150 Macy's closures, store growth across luxury (+30 Bluemercury & +15 Bloomies) and small format (+30), and private label and inventory... More
Macy's (M) PT Raised to $22 at Citi, 'We Lean More Positive but Stay Neutral'
February 28, 2024 3:19 AM ESTCiti analyst Paul Lejuez raised the price target on Macy's (NYSE: M) to $22.00 (from $18.00) while maintaining a Neutral rating.
The analyst comments "4Q GM/EPS beat consensus though sales were still weak (comps -5%) and mgmt is looking for a sales decline in... More
CFRA Downgrades Macy's (M) to Hold
February 27, 2024 12:55 PM ESTCFRA analyst Zachary Warring downgraded Macy's (NYSE: M) from Buy to Hold with a price target of $18.00 (from $19.00).
The analyst comments "We lower our 12-month price target by $1 to $18, based on 7.2x our FY 25 (Jan.) EPS estimate and in line with the company's... More
Viking Therapeutic (VKTX) PT Raised to $80 at Stifel, '“Best-in-Class” Profile of Injectable VK2735 Stands Firm'
February 27, 2024 12:06 PM ESTStifel analyst Samimy Annabel raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $80.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Ahead of schedule, VKTX released the Ph.2 VENTURE data for injectable-VK2735, which again demonstrated a highly competitive profile relative to... More
AutoZone (AZO) PT Raised to $3,200 at CFRA, 'We...like AZO's robust international growth'
February 27, 2024 12:04 PM ESTCFRA analyst Garrett Nelson raised the price target on AutoZone (NYSE: AZO) to $3,200.00 (from $3,000.00) while maintaining a Buy rating.
The analyst comments "We lift our 12-month target to $3,200 from $3,000, based on a FY 25 (Aug.) P/E of 19.0x, a premium to... More
